Technical Analysis for ARAV - Aravive, Inc.

Grade Last Price % Change Price Change
grade D 7.69 16.52% 1.09
ARAV closed up 16.52 percent on Tuesday, March 19, 2019, on 4.29 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Up Up
See historical ARAV trend table...

Date Alert Name Type % Chg
Mar 19 200 DMA Resistance Bearish 0.00%
Mar 19 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 19 Expansion Breakout Bullish Swing Setup 0.00%
Mar 19 Pocket Pivot Bullish Swing Setup 0.00%
Mar 19 Volume Surge Other 0.00%
Mar 19 Wide Range Bar Range Expansion 0.00%
Mar 19 Parabolic Rise Strength 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Above Upper BB Strength 0.00%
Mar 19 Gapped Up Strength 0.00%

Older signals for ARAV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. It is developing AVB-S6-500, a GAS6 binding protein and AXL decoy receptor, for the treatment of ovarian cancer, as well as for renal cell carcinoma, acute myeloid leukemia, triple negative breast cancer and pancreatic cancer. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is based in Houston, Texas.
Biotechnology Cancer Solid Tumors Ovarian Cancer Cell Biology Acute Myeloid Leukemia Pancreatic Cancer Hematologic Malignancies Bemcentinib Renal Cell Carcinoma Treatment Of Ovarian Cancer Triple Negative Breast Cancer Book:Cancer
Is ARAV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.3
52 Week Low 3.07
Average Volume 29,188
200-Day Moving Average 7.7279
50-Day Moving Average 4.9119
20-Day Moving Average 6.072
10-Day Moving Average 6.583
Average True Range 0.5316
ADX 48.2
+DI 35.9847
-DI 8.981
Chandelier Exit (Long, 3 ATRs ) 6.2552
Chandelier Exit (Short, 3 ATRs ) 6.2948
Upper Bollinger Band 7.3783
Lower Bollinger Band 4.7657
Percent B (%b) 1.12
BandWidth 43.027009
MACD Line 0.5423
MACD Signal Line 0.5012
MACD Histogram 0.0412
Fundamentals Value
Market Cap 273.6 Million
Num Shares 35.6 Million
EPS -3.45
Price-to-Earnings (P/E) Ratio -2.23
Price-to-Sales 0.00
Price-to-Book 0.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.54
Resistance 3 (R3) 9.39 8.62 9.23
Resistance 2 (R2) 8.62 8.15 8.69 9.13
Resistance 1 (R1) 8.15 7.86 8.39 8.31 9.02
Pivot Point 7.39 7.39 7.50 7.46 7.39
Support 1 (S1) 6.92 6.92 7.15 7.07 6.36
Support 2 (S2) 6.15 6.63 6.23 6.25
Support 3 (S3) 5.69 6.15 6.15
Support 4 (S4) 5.84